drugset / Trial / NCT06726863
Pharmacokinetics and Pharmacodynamics of Two Prolonged-release Formulations of Vamifeport in Healthy Adults
RandomizedSequentialOpen-labelOther
Summary
This is a phase 1, single-center, randomized, open-label study to characterize the pharmacokinetics (PK), pharmacodynamics (PD), and safety of vamifeport after multiple oral administrations of one immediate-release (IR) formulation and after single and multiple oral administrations of two prolonged-release (PR) formulation in healthy adult participants.
Timeline
- Start
- 2024-11-22
- Primary completion
- 2025-01-27
- Completion
- 2025-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vamifeport | Small molecule | — | Oral |
Indications
No indication recorded.